Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,355,004 papers from all fields of science
Search
Sign In
Create Free Account
ACTIVATED PI3K-DELTA SYNDROME
Known as:
PASLI
, APDS
, p110-DELTA-ACTIVATING MUTATION CAUSING SENESCENT T CELLS, LYMPHADENOPATHY, AND IMMUNODEFICIENCY
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Autosomal dominant inheritance
Bronchiectasis
Cellulitis
Hypogammaglobulinemia
Expand
Broader (2)
Class I Phosphatidylinositol 3-Kinases
Immunologic Deficiency Syndromes
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
The Treatment of Activated PI3Kδ Syndrome
T. Coulter
,
A. Cant
Frontiers in Immunology
2018
Corpus ID: 52171039
Activated phosphoinositide 3-kinase δ syndrome (APDS), also known as PASLI disease (p110d-activating mutation causing senescent T…
Expand
Review
2018
Review
2018
Respiratory Manifestations of the Activated Phosphoinositide 3-Kinase Delta Syndrome
Alison M. Condliffe
,
Anita Chandra
Frontiers in Immunology
2018
Corpus ID: 3692750
The activated phosphoinositide 3-kinase δ syndrome (APDS), also known as p110δ-activating mutation causing senescent T cells…
Expand
Highly Cited
2017
Highly Cited
2017
Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors.
K. Hoegenauer
,
Nicolas Soldermann
,
+11 authors
C. Burkhart
ACS Medicinal Chemistry Letters
2017
Corpus ID: 34262513
The predominant expression of phosphoinositide 3-kinase δ (PI3Kδ) in leukocytes and its critical role in B and T cell functions…
Expand
Review
2016
Review
2016
Genomics of Immune Diseases and New Therapies.
M. Lenardo
,
Bernice Lo
,
C. Lucas
Annual Review of Immunology
2016
Corpus ID: 207681781
Genomic DNA sequencing technologies have been one of the great advances of the 21st century, having decreased in cost by seven…
Expand
2011
2011
InGaAs-InP avalanche photodiodes with dark current limited by generation-recombination.
Yanli Zhao
,
Dongdong Zhang
,
+7 authors
Wen Liu
Optics Express
2011
Corpus ID: 25258504
Separate absorption grading charge multiplication avalanche photodiodes (SAGCM APDs) are widely accepted in photon starved…
Expand
2006
2006
The N‐terminus of phosphoinositide 3‐kinase‐C2β regulates lipid kinase activity and binding to clathrin
M. Wheeler
,
J. Domin
Journal of Cellular Physiology
2006
Corpus ID: 22438752
The class II phosphoinositide 3‐kinase (PI3K)‐C2β is recruited to polypeptide growth factor receptors following ligand…
Expand
Highly Cited
2005
Highly Cited
2005
Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration
T. Maffucci
,
F. Cooke
,
Fiona M. Foster
,
Colin J. Traer
,
M. J. Fry
,
M. Falasca
Journal of Cell Biology
2005
Corpus ID: 2182023
The lipid products of phosphoinositide 3-kinase (PI3K) are involved in many cellular responses such as proliferation, migration…
Expand
2003
2003
Nuclear phosphoinositide 3-kinase C2beta activation during G2/M phase of the cell cycle in HL-60 cells.
D. Visnjic
,
J. Ćurić
,
V. Crljen
,
D. Batinić
,
S. Volinia
,
H. Banfić
Biochimica et Biophysica Acta
2003
Corpus ID: 23602112
Highly Cited
2001
Highly Cited
2001
Presence and Activation of Nuclear Phosphoinositide 3-Kinase C2β during Compensatory Liver Growth*
Aleksandra Sinđić
,
A. Aleksandrova
,
A. Fields
,
S. Volinia
,
H. Banfić
Journal of Biological Chemistry
2001
Corpus ID: 29324615
Highly purified liver nuclei incorporated radiolabeled phosphate into phosphatidylinositol 4-phosphate (PtdIns(4)P), PtdIns(4,5…
Expand
Highly Cited
2001
Highly Cited
2001
Recruitment of the Class II Phosphoinositide 3-Kinase C2β to the Epidermal Growth Factor Receptor: Role of Grb2
M. Wheeler
,
J. Domin
Molecular and Cellular Biology
2001
Corpus ID: 44260224
ABSTRACT Previously we demonstrated that the class II phosphoinositide 3-kinase C2β (PI3K-C2β) is rapidly recruited to a…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required